ConditionBones, joints & muscles

Inflammatory Myopathy (Myositis)

Inflammatory myopathies, also called myositis, are a group of rare autoimmune diseases in which the immune system attacks muscle, causing weakness that usually affects the hips, thighs, shoulders and neck on both sides. The main types are dermatomyositis (with a skin rash), immune-mediated necrotizing myopathy, antisynthetase syndrome, polymyositis and inclusion body myositis. Many also affect the lungs, joints, heart or swallowing. Most types respond to steroids and immune-suppressing drugs, except inclusion body myositis.

Also called: Idiopathic inflammatory myopathy, myositis, autoimmune myositis, dermatomyositis, polymyositis

At a glance

What it is
Autoimmune inflammation of skeletal muscle causing weakness.
Main types
Dermatomyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, overlap myositis, polymyositis and inclusion body myositis.
Key symptom
Gradual weakness of hips, thighs, shoulders and neck: trouble climbing stairs, rising from a chair or lifting arms.
Diagnosis
CK blood test, myositis antibodies, MRI, EMG and muscle biopsy.
Treatment
Steroids, methotrexate, azathioprine, mycophenolate, IVIG, rituximab, and exercise therapy. Cancer screening for dermatomyositis.

When to get help

Call 911 or go to the ER

  • Difficulty breathing or swallowing, choking on food or drink, or a weak cough: call 911
  • Severe weakness with dark, cola-colored urine (possible rhabdomyolysis)
  • Chest pain, palpitations or fainting with muscle weakness (possible heart involvement)

See a doctor within a day or two

  • Rapidly worsening weakness over days to weeks
  • New breathlessness or dry cough in someone with myositis (possible lung disease)
  • Fever or infection while taking immune-suppressing drugs

Book a routine appointment

  • Gradual difficulty climbing stairs, getting up from a chair, combing hair or lifting objects overhead
  • A purple rash on the eyelids or red bumps over the knuckles with weakness
  • Muscle aches and weakness that started after taking a statin and did not go away after stopping it
  • Slowly progressive weakness of finger grip and thigh muscles in someone over 50

How inflammatory myopathies work

In myositis, the immune system targets muscle tissue. In dermatomyositis, it damages small blood vessels in muscle and skin. In necrotizing myopathy, antibodies cause muscle fibers to die. In inclusion body myositis, inflammation and degeneration occur together. The common result is muscle weakness, sometimes with pain, plus effects on other organs.

Types of inflammatory myopathy

TypeKey featuresTypical age
DermatomyositisWeakness plus a purple rash on the eyelids, red scaly bumps over knuckles (Gottron papules), rash on the chest, back and shoulders. Linked with cancer in adultsAdults 40 to 60. Juvenile form in children
Immune-mediated necrotizing myopathySevere weakness, very high CK. Antibodies to SRP or HMGCR. HMGCR form can follow statin useAny adult age
Antisynthetase syndromeMyositis, interstitial lung disease, arthritis, fever, cracked "mechanic's hands", Raynaud's. Anti-Jo-1 and related antibodiesAdults
Overlap myositisMyositis with lupus, scleroderma, Sjogren's or mixed connective tissue diseaseAdults
PolymyositisWeakness without rash. Now diagnosed less often as other types are recognizedAdults
Inclusion body myositisSlowly progressive weakness of thigh muscles and finger flexors, often asymmetric, with swallowing problems. Does not respond to immune treatmentUsually over 50, more in men

Symptoms

Muscle symptoms

  • weakness of hip and shoulder muscles: difficulty climbing stairs, getting up from low chairs or the floor, lifting arms to wash hair
  • neck weakness, difficulty lifting the head
  • muscle aches or tenderness in some people
  • fatigue
  • in inclusion body myositis: weak grip, frequent falls from knee buckling

Symptoms beyond muscle

  • skin: heliotrope rash, Gottron papules, sun-sensitive rash, cracked fingertips, calcium deposits in children
  • lungs: dry cough and breathlessness from interstitial lung disease, which can be the main problem
  • swallowing: difficulty swallowing, choking, nasal voice
  • joints: arthritis
  • heart: rhythm problems or inflammation, uncommon
  • Raynaud's phenomenon
  • general: fever and weight loss

Causes and risk factors

The cause is unknown. Contributing factors include genetic susceptibility, environmental triggers such as sunlight (dermatomyositis), viral infections, certain medicines (statins in HMGCR myopathy, immune checkpoint inhibitors for cancer) and, in dermatomyositis, an underlying cancer.

Diagnosis

  • Creatine kinase (CK): a muscle enzyme, usually raised, sometimes very high in necrotizing myopathy.
  • Myositis-specific and myositis-associated antibodies: help classify the type and predict lung disease, cancer risk and response to treatment.
  • MRI of muscles: shows inflammation and guides where to biopsy.
  • Electromyography (EMG): shows a muscle pattern of damage.
  • Muscle biopsy: confirms inflammation and distinguishes types. Skin biopsy may help in dermatomyositis.
  • Lung tests: high-resolution CT and lung function tests.
  • Heart tests: ECG, troponin and echocardiogram.
  • Swallowing studies if needed.
  • Cancer screening in dermatomyositis and some other types, typically CT scans and age-appropriate screening, as cancer risk is raised for about 3 years around diagnosis.

Doctors also exclude other causes of weakness: statin-induced myopathy without antibodies, thyroid disease, muscular dystrophies, metabolic myopathies, myasthenia gravis and medication effects.

Treatment

  • Corticosteroids (prednisone, sometimes IV methylprednisolone pulses) as the initial treatment for most types.
  • Steroid-sparing drugs: methotrexate, azathioprine or mycophenolate, started early to allow steroids to be reduced.
  • IVIG: effective for dermatomyositis (FDA approved) and necrotizing myopathy, and helpful for swallowing problems.
  • Rituximab, tacrolimus or cyclophosphamide for resistant disease or significant lung involvement.
  • Skin care for dermatomyositis: strict sun protection, hydroxychloroquine and topical treatments.
  • Inclusion body myositis: no proven drug treatment. Management focuses on exercise, assistive devices and swallowing support.
  • Exercise and physical therapy: safe and beneficial, improving strength and function once inflammation is controlled.
  • Bone protection while on steroids, and infection prevention with vaccines.

Outlook

With treatment, most people with dermatomyositis, antisynthetase syndrome and necrotizing myopathy regain much of their strength, though recovery takes months and many need long-term treatment. Lung disease and associated cancer are the main factors affecting survival. Inclusion body myositis progresses slowly over years, and most people eventually need walking aids.

Frequently asked questions

What is inflammatory myopathy?

Inflammatory myopathy, or myositis, is a group of autoimmune diseases in which the immune system attacks muscle, causing weakness, usually of the hips, thighs, shoulders and neck. Some types also affect the skin, lungs, joints, heart or swallowing.

What are the types of myositis?

The main types are dermatomyositis, immune-mediated necrotizing myopathy, antisynthetase syndrome, overlap myositis, polymyositis and inclusion body myositis. They differ in symptoms, antibodies, associated conditions and response to treatment.

What is the difference between dermatomyositis and polymyositis?

Both cause muscle weakness, but dermatomyositis also causes a characteristic skin rash, such as a purple rash on the eyelids or red bumps over the knuckles, and carries a higher cancer risk in adults. Polymyositis affects muscles without a rash.

Can statins cause myositis?

Statins commonly cause mild muscle aches that go away when the drug is stopped. Rarely, they trigger an autoimmune necrotizing myopathy with anti-HMGCR antibodies, in which weakness continues or worsens after stopping the statin and needs immune treatment.

Is myositis curable?

Some people achieve long-term remission and can stop treatment, especially with dermatomyositis. Others need ongoing treatment to control disease. Inclusion body myositis does not respond to current immune treatments, and management focuses on maintaining function.

Sources

This guide was written from current patient and clinical guidance, including:

  • The Myositis Association: Types of myositis
  • National Institute of Neurological Disorders and Stroke: Inflammatory myopathies
  • American College of Rheumatology: Myositis
  • EULAR/ACR: Classification criteria for adult and juvenile idiopathic inflammatory myopathies
  • MedlinePlus: Polymyositis; Dermatomyositis